Scientists from the Pasteur Institute in France have discovered new antibodies against HIV. EPTC112 neutralizes approximately one-third of the 200 viral variants of the disease. Research results published In the journal Nature.
HIV (human immunodeficiency virus) is an infectious chronic disease transmitted by contact, slowly progressing and characterized by damage to the immune system with the development of acquired immunodeficiency syndrome (AIDS).
There are HIV-1 carriers who, by starting treatment immediately and continuing it for several years, can prevent the development of AIDS even after treatment is stopped.
A group of immunologists discovered that such people have special antibodies. One of the most active is the EPTC112 antibody, which neutralizes about a third of the 200 viral variants of HIV-1. It has the ability to destroy infected cells of the immune system. Moreover, scientists suggest that such protection is provided not only by antibodies, but also by a complex of different molecules.
The immunologists added that the study contributes to a better understanding of the mechanisms underlying viral control. This discovery could be the first step towards new HIV-1 treatments based on the use of neutralizing antibodies.
existed before listed The most “cunning” viruses that infect humans.